214 related articles for article (PubMed ID: 27540303)
1. The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review.
Zhang X; Yu J; Li M; Zhu H; Sun X; Kong L
Onco Targets Ther; 2016; 9():4901-11. PubMed ID: 27540303
[TBL] [Abstract][Full Text] [Related]
2. The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.
Zhang L; Han J; Wu H; Liang X; Zhang J; Li J; Xie L; Xie Y; Sheng X; Yu J
PLoS One; 2014; 9(10):e110626. PubMed ID: 25356587
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma.
Yao X; Zhao G; Yang H; Hong X; Bie L; Liu G
J Cancer Res Clin Oncol; 2010 May; 136(5):677-84. PubMed ID: 19898867
[TBL] [Abstract][Full Text] [Related]
4. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
5. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Li C; Zuo D; Yin L; Lin Y; Li C; Liu T; Wang L
Gastroenterol Res Pract; 2018; 2018():6986870. PubMed ID: 29967641
[TBL] [Abstract][Full Text] [Related]
7. [The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus].
Niu S; Zhao ZG; Lyu XM; Zhao M; Wang XZ; Liu WN; Zhao W; Zhang XH; Wang Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):391-395. PubMed ID: 32482028
[No Abstract] [Full Text] [Related]
8. Prognostic and Clinicopathological Significance of SATB1 in Colorectal Cancer: A Meta-Analysis.
Zhao J; Tuo Y; Luo W; He S; Chen Y
Front Physiol; 2018; 9():535. PubMed ID: 29867574
[No Abstract] [Full Text] [Related]
9. Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
Wu Y; Chen C; Hua X; Zhao C; Min H
BMC Cancer; 2024 Apr; 24(1):537. PubMed ID: 38678238
[TBL] [Abstract][Full Text] [Related]
10. [Expression of high mobility group box-1 in colorectal cancer and its clinical significance].
Li Z; Wang H; Song B; Sun Y; Han J; Xu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jun; 18(6):616-9. PubMed ID: 26108781
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis.
Zheng CG; Jin C; Ye LC; Chen NZ; Chen ZJ
Tumour Biol; 2015 Aug; 36(8):5839-48. PubMed ID: 25716203
[TBL] [Abstract][Full Text] [Related]
12. Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis.
Wang H; Li Z; Sun Y; Xu Z; Han J; Song B; Song W; Qin C; Yin L
Onco Targets Ther; 2015; 8():3523-31. PubMed ID: 26664135
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinical significance of claudin-1 in colorectal cancer: A systemic review and meta-analysis.
Jiang L; Yang L; Huang H; Liu BY; Zu G
Int J Surg; 2017 Mar; 39():214-220. PubMed ID: 28192244
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.
Zu G; Ji A; Zhou T; Che N
Int J Surg; 2016 Feb; 26():32-7. PubMed ID: 26763348
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer.
Ueda M; Takahashi Y; Shinden Y; Sakimura S; Hirata H; Uchi R; Takano Y; Kurashige J; Iguchi T; Eguchi H; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Anticancer Res; 2014 Oct; 34(10):5357-62. PubMed ID: 25275029
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
[TBL] [Abstract][Full Text] [Related]
17. The Relationship between Telomerase Activity and Clinicopathological Parameters in Colorectal Cancer: A Meta-Analysis.
Xie XC; Ge LY; Lai H; Qiu H; Tang F; Qin YZ
Balkan Med J; 2016 Jan; 33(1):64-71. PubMed ID: 26966620
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis.
Wei HT; Guo EN; Dong BG; Chen LS
BMC Gastroenterol; 2015 Oct; 15():152. PubMed ID: 26518017
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of urokinase plasminogen activator receptor in gastric and colorectal cancer: A systematic review and meta-analysis.
Guo H; Ling C; Ma YY; Zhou LX; Zhao L
Onco Targets Ther; 2015; 8():1503-9. PubMed ID: 26150727
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
